Company profile: Clintrak
1.1 - Company Overview
Company description
- Provider of clinical-trial printing and labeling solutions, including design and production of single panel and booklet labels for use in clinical trials.
Products and services
- Clinical-Trial Label Design & Printing: Architects and produces responsive, accurate, high-quality labeling components for pharmaceutical clinical trials, spanning label design and production
- Custom-engineered
- Booklet Label Printing: Delivers printing of booklet labels used in clinical trials to present detailed information to participants and staff
- Clinical-trial-specific
- Single Panel Label Printing: Produces single-panel labels used in clinical trials with accurate, high-quality printing outputs and responsive turnaround
- High-accuracy
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Clintrak
ClinEdge
HQ: United States
Website
- Description: Provider of a full suite of clinical and trial management solutions to clinical research institutions, pharmaceutical companies, and CROs, providing business development and patient recruitment services and facilitating every stage of the clinical trial process, from site selection to staff support to patient engagement.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ClinEdge company profile →
PharmaCell
HQ: The Netherlands
Website
- Description: Provider of GMP-certified cell-culturing and contract manufacturing services for cellular therapies and regenerative medicine in Europe, operating facilities in Maastricht and Geleen. Serves world-leading commercial cell therapy companies and offers support or partnership to R&D companies through an extensive network.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaCell company profile →
Synteract HCR
HQ: United States
Website
- Description: Provider of global full-service contract research organization support for biotechnology, medical device, and pharmaceutical companies across all phases of clinical development, delivering customized Phase I–IV services collaboratively and cost effectively.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synteract HCR company profile →
UAS Labs
HQ: United States
Website
- Description: Provider of science-backed probiotic solutions, offering documented strains for gut, immune, and women’s health; co-development of customized formulations, including those based on L. acidophilus DDS-1; and the STRAIN TO SOLUTION process ensuring stability and safety from development to final product. Also provides The Probiotics Institute educational platform and SCIENCE by Chr. Hansen strains supported by human clinical data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full UAS Labs company profile →
Tetris Pharma
HQ: United Kingdom
Website
- Description: Provider of a pan-European platform to market a range of prescription products, offered by a UK-based speciality pharmaceutical company with extensive experience of launching products in the UK and across Europe, focused on areas of unmet clinical need.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tetris Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Clintrak
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Clintrak
2.2 - Growth funds investing in similar companies to Clintrak
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Clintrak
4.2 - Public trading comparable groups for Clintrak
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →